MCT Oil in viral respiratory tract infection in patient with metabolic syndrome

Phase 3

Recruiting

• Conditions: Condition 1: COVID-19. Condition 2: Seasonal Influenza. Condition 3: Adult Cold.; Other coronavirus as the cause of diseases classified elsewhere; B97.29

• Registration Number: IRCT20201019049079N1
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 12 July 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Informed consent
Metabolic Syndrome as defined by the International Diabetes Federation (IDF): Abdominal obesity above 94 cm in men and 80 cm in women plus two of the following criteria: IFG above 100, triglyceride above 150, HDL below 40 in men and below 50 in women And have systolic blood pressure above 130 mmHg or diastole above 85 mmHg
Symptoms of viral respiratory tract infection

Exclusion Criteria

Drug allergy
Pregnancy / breastfeeding
Asthma and allergies
CHF
CRF
malignancy
Immune system defects such as AIDS and corticosteroids

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Symptoms of viral respiratory tract infection (fever, cough, body aches, shortness of breath). Timepoint: Days 0 (visit day) ,1,2,3,4,7 and 14. Method of measurement: Questionnaire and question from the patient.